Accès ouvert

Usefulness of three protein signatures (Mastocheck) for follow-up after breast cancer surgery

Article scientifique 2022 Anglais

Résumé

Abstract Purpose: This study aimed to evaluate whether the three protein markers that we had developed previously for early breast cancer diagnosis, are useful for postoperative follow-up. Methods: Of 111 patients with breast cancer that were prospectively enrolled and underwent blood tests before, 8-weeks, 6-months, or 1-year after surgery, 53 underwent serial tests preoperatively to 1-year postoperatively. Protein biomarker changes were analyzed before and after surgery. Moreover, 145 patients who underwent surgery >1 year previously, were prospectively enrolled into the recurrence and non-recurrence (no evidence of disease; NED) groups. Using traditional and artificial intelligence analysis methods, we determined whether the biomarkers could identify disease presence or absence, and evaluated whether significant correlation occurred in biomarker changes. Results: Of the 111 included patients, 105 and 53 were followed-up for 8 weeks and 6 months to 1 year after surgery, respectively. Preoperatively, biomarker diagnostic sensitivity was 73.0%; 8-weeks and 6-months to 1-year after surgery, normalized blood biomarker level occurred in 67.6% and 86.8% of patients, respectively. Among 53 patients with serial tests, preoperative test sensitivity was 73.6%, which normalized after 6 month in 86.8%. Greater than 1-year after surgery, 38/63 patients with recurrence developed cancer, and 66/81 NED patients were cancer-free (62.5% sensitivity; 81.5% specificity). The upgraded version of biomarker analysis confirmed a further improved performance (with recurrence, 82.5% sensitivity; with NED, 87.7% specificity). Conclusions: Blood protein signatures (Mastocheck) developed for early breast cancer diagnosis normalized over time postoperatively, and could be used as a biological monitoring test after breast cancer surgery.

Citer ce document

Kim, Y., Noh, D., Lim, C., Kim, H., Kim, S., Ahn, K. (2022). Usefulness of three protein signatures (Mastocheck) for follow-up after breast cancer surgery. https://doi.org/10.21203/rs.3.rs-1556170/v1

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Statistiques

Consultations : 1

Téléchargements : 0